Morning Market Gainers

shares jumped 40.91 percent to $3.72 on CF102 NASH data.

shares surged 24.05 percent to $22.64 after jumping 75.48 percent on Friday. KaloBios Pharma named Martin Shkreli as CEO and announced a new financing.

shares rose 12.53 percent to $4.94 after

announced plans to acquire TeleCommunication Systems for $430.8 million.

surged 11.51 percent to $24.58 after new Phase 3 data showed that "glioblastoma patients who received TTFields in combination with chemotherapy at first recurrence lived significantly longer than patients who received chemotherapy alone."

shares climbed 11.07 percent to $12.54 after the company agreed to divest coal assets in New Mexico and Colorado for $358 million.

gained 9.96 percent to $2.76 after the company reported that it has suspended clinical dosing of APTO-253 to review its drug manufacturing processes and procedures.

surged 9.14 percent to $1.20 after the company reported that it has initiated rolling submission of U.S. NDA for pacritinib for the treatment of patients with myelofibrosis.

rose 7.15 percent to $65.36 after the company reported better-than-expected results for its fiscal fourth quarter on Monday.

shares gained 2.99 percent to $16.18 following announcement of a $500 million investment by the HNA Tourism Group.